Fierce Pharma Biopharma News & Insights
WEB6 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
FDA signs off on first engineered cell therapy for a solid tumor
WEB1 day ago · FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor. By Kevin Dunleavy Aug 2, 2024 8:56am. Adaptimmune soft tissue sarcoma T-cell therapy Galapagos ...
Top 20 pharma companies by 2023 revenue
WEB2023 revenue: $85.16 billion. 2022 revenue: $79.99 billion. Change: +6.5%. Headquarters: New Brunswick, New Jersey. Welcome back to the top, Johnson & Johnson. After a brief stint at No. 2 in ...
Pharma | Fierce Pharma
WEBSanofi has filed a complaint claiming that in producing Duchenne muscular dystrophy treatment Elevidys, Sarepta encroaches on two of its patents. Kevin Dunleavy Jul 30, 2024 5:21pm. Connect. The Team.
The top 20 drugs by 2021 sales - Fierce Pharma
WEBAs expected, Merck & Co.’s Keytruda was the world’s best-selling cancer drug—again—in 2021. With a $17.19 billion showing and 19.5% year-over-year growth, Keytruda's haul came in more than ...
Big Pharma Companies Ranked by Revenue 2022 | Fierce Pharma
WEBFor the first time in biopharma history, a company has topped the $100 billion mark in annual revenue. Pfizer passed that milestone, propelled by its massive haul from its COVID-19 products. Its ...
Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive
WEB4 days ago · That means Pfizer's 2024 revenues are now expected to fall somewhere between $59.5 billion and $62.5 billion, a 9% to 11% growth rate sans COVID product sales. CEO Albert Bourla pointed to ...
The top 20 pharma companies by 2021 revenue | Fierce Pharma
WEBIt was a good year to be a pharmaceutical company, especially one that came up with a product to combat COVID-19. Of the world’s top 20 pharmas ranked by 2021 revenues, 12 had at least 10% ...
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
WEBMar 29, 2021 · The pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. As 2020 progressed, drugmakers battled the coronavirus on one hand and on the other ...
Pfizer takes on Novartis with FDA nod for lung cancer combo
WEBOct 12, 2023 · Similar to the Novartis combo’s approval in 2017, Pfizer won over the FDA with tumor response data from a single-arm phase 2 trial. In the PHAROS study, the Pfizer regimen shrank tumors in 75% ...
Skip to content